- Home
- BGM vs CIM Comparison
BGM vs CIM Comparison
Compare BGM & CIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGM
- CIM
- Stock Information
- Founded
- BGM 2019
- CIM 2007
- Country
- BGM China
- CIM United States
- Employees
- BGM N/A
- CIM N/A
- Industry
- BGM
- CIM Real Estate Investment Trusts
- Sector
- BGM
- CIM Real Estate
- Exchange
- BGM NYSE
- CIM Nasdaq
- Market Cap
- BGM 962.5M
- CIM 1.1B
- IPO Year
- BGM 2021
- CIM 2007
- Fundamental
- Price
- BGM $11.35
- CIM $13.10
- Analyst Decision
- BGM
- CIM Hold
- Analyst Count
- BGM 0
- CIM 2
- Target Price
- BGM N/A
- CIM $16.00
- AVG Volume (30 Days)
- BGM 25.7K
- CIM 587.6K
- Earning Date
- BGM 04-08-2025
- CIM 05-08-2025
- Dividend Yield
- BGM N/A
- CIM 11.30%
- EPS Growth
- BGM N/A
- CIM 61.77
- EPS
- BGM N/A
- CIM 1.10
- Revenue
- BGM $25,097,951.00
- CIM $277,886,000.00
- Revenue This Year
- BGM N/A
- CIM $11.61
- Revenue Next Year
- BGM N/A
- CIM $1.50
- P/E Ratio
- BGM N/A
- CIM $11.90
- Revenue Growth
- BGM N/A
- CIM 22.95
- 52 Week Low
- BGM $2.70
- CIM $11.29
- 52 Week High
- BGM $14.78
- CIM $16.89
- Technical
- Relative Strength Index (RSI)
- BGM 59.03
- CIM 33.63
- Support Level
- BGM $10.31
- CIM $13.01
- Resistance Level
- BGM $11.90
- CIM $13.37
- Average True Range (ATR)
- BGM 1.00
- CIM 0.29
- MACD
- BGM 0.17
- CIM -0.03
- Stochastic Oscillator
- BGM 65.69
- CIM 15.26
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
About CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.